75N91023F00021: Leidos Biomedical Research Inc · FederalPipeline
75N91023F00021: Leidos Biomedical Research Inc
Delivery Order to Leidos Biomedical Research Inc by National Institutes of Health: $1.6M obligated, latest action 2023-09-05. Drug Product Formulation…